Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In the SURMOUNT-1 trial, patients without diabetes treated with tirzepatide 15 mg achieved a mean weight reduction of 16.0% at 72 weeks [22], while semaglutide 2.4 mg in the STEP-1 trial yielded a 14.9% reduction over a similar period (treatment regimen estimand) [23]
/sc-assets/prd/practices/cdcd65da-a892-465a-aa2c-48d5c1f8134f/Tirzepatide%20vial.png)
Retatrutide CAS Registry Number 2381089 83 2 is a highly modified synthetic 39 amino acid peptide backbone engineered to display co agonist activity across three distinct incretin receptor networks
Overdose No cases of overdosage have been reported in the literature
Tirzepatide may offer the potential for greater weight loss compared to Ozempic due to its dual action on multiple hormonal pathways involved in appetite regulation and metabolism
US$ 20.53
US$ 25.15
US$ 22.66
US$ 25.10
